There are five committees under the Board of Directors: Strategy Planning Committee, Audit Committee, Remuneration Committee, Safety, Health and Environmental Committee and Nomination Committee.

I.Strategy Planning Committee
The primary duties of the Strategy Planning Committee are to formulate our overall development plans and investment decision-making procedures.
The Strategy Committee currently consists of Dr. Zhang Xiwu, who serves as its chairman, and Dr. Ling Wen.

II. Audit Committee
The primary duties of the Audit Committee are to review and supervise our financial reporting process. The Audit Committee currently consists of three independent non-executive Directors, Dr. Chen Xiaoyue, who serves as its chairman, Mr. Huang Yicheng and Mr. Anthony Francis Neoh.

III.Remuneration Committee
The primary duties of the Remuneration Committee are to formulate the training and compensation policies and to determine and manage the compensation of our senior management. The Remuneration Committee currently consists of two independent non-executive Directors, Mr. Anthony Francis Neoh, who serves as its chairman, and Dr. Chen Xiaoyue and Dr. Ling Wen, an executive Director.

IV.Safety, Health and Environmental Committee
The primary duties of the Safety, Health and Environmental Committee are to ensure that appropriate performance targets and benchmarks are in place for our health, safety and environmental obligations, as well as to monitor potential liabilities, changes in regulations, community expectations and technological changes which relate to safety, health and environmental issues.
The Safety, Health and Environment committee currently consists of Mr. Huang Yicheng, who serves as its chairman, Dr. Zhang Yuzhuo and Mr. Han Jianguo.

V. Nomination Committee
The primary duties of the Nomination Committee are to improve the structure of the Company’s corporate governance, standardizing the nomination procedures of the directors and senior management personnel and selecting well-qualified directors and senior management personnel of the Company.
The Nomination Committee currently consists of Dr. Zhang Xiwu, who served as its chairman, Mr Huang Yicheng, Mr Anthony Francis Neoh and Dr. Chen Xiaoyue.